Helmholtz Centre for Environmental Research (UFZ), Department of Environmental Immunology, Leipzig, Germany.
Helmholtz Centre for Environmental Research (UFZ), Department of Systems Biology, Leipzig, Germany.
Int J Obes (Lond). 2017 Sep;41(9):1440-1446. doi: 10.1038/ijo.2017.113. Epub 2017 May 10.
The maternal inflammation status during pregnancy has been associated with metabolic imprinting and obesity development in the child. However, the influence of the maternal Th2 cytokines, interleukin-4 (IL4), IL5 and IL13, has not been studied so far.
We investigated the relationship between maternal innate (IL6, IL8, IL10 and tumor necrosis factor-α (TNFa)) and adaptive (interferon-γ, IL4, IL5 and IL13) blood cytokine levels at 34 weeks of gestation and children's overweight development until the age of 3 years in 407 children of the German longitudinal LINA (Lifestyle and Environmental Factors and their Influence on Newborns Allergy risk) cohort. Children's body weight and height were measured during the annual clinical visits or acquired from questionnaires. Body mass index (BMI) Z-scores were calculated according to the WHO reference data to adjust for child's age and gender. Cytokine secretion was stimulated with phytohemagglutinin or lipopolysaccharide and measured by cytometric bead assay. Furthermore, we assessed metabolic parameter in blood of 318 children at age 1 using the AbsoluteIDQ p180 Kit (Biocrates LIFE Science AG).
Applying logistic regression models, we found that an increase of maternal IL4 and IL13 was associated with a decreased risk for overweight development in 1- and 2-year-old children. This effect was consistent up to the age of 3 years for IL13 and mainly concerns children without maternal history of atopy. Children's acylcarnitine concentrations at 1 year were positively correlated with maternal IL13 levels and inversely associated with the BMI Z-score at age 1.
We were able to show for the first time that the maternal Th2 status may be linked inversely to early childhood overweight development accompanied by an altered metabolic profile of the fetus. However, our data do not support a direct mediating role of acylcarnitines on maternal IL13-induced weight development.
孕期母体炎症状态与儿童代谢印迹和肥胖发展有关。然而,目前尚未研究母体 Th2 细胞因子白细胞介素-4(IL-4)、IL-5 和 IL-13 的影响。
我们研究了 407 名德国纵向 LINA(生活方式和环境因素及其对新生儿过敏风险的影响)队列中 34 周妊娠时母体固有(IL-6、IL-8、IL-10 和肿瘤坏死因子-α(TNF-α))和适应性(干扰素-γ、IL-4、IL-5 和 IL-13)血液细胞因子水平与儿童超重发展之间的关系,直到 3 岁。在每年的临床访视中测量儿童的体重和身高,或从问卷中获取。根据世界卫生组织参考数据计算体重指数(BMI)Z 分数,以调整儿童的年龄和性别。用植物血凝素或脂多糖刺激细胞因子分泌,并用细胞计数珠分析测定。此外,我们在 318 名儿童 1 岁时使用 AbsoluteIDQ p180 试剂盒(Biocrates LIFE Science AG)评估血液中的代谢参数。
应用逻辑回归模型,我们发现母体 IL-4 和 IL-13 增加与 1 岁和 2 岁儿童超重发展风险降低相关。这种效应在 IL-13 中一直持续到 3 岁,主要涉及无母体特应性病史的儿童。儿童 1 岁时的酰基辅酶 A 浓度与母体 IL-13 水平呈正相关,与 1 岁时的 BMI Z 分数呈负相关。
我们首次表明,母体 Th2 状态可能与胎儿早期超重发展呈负相关,同时伴有代谢特征改变。然而,我们的数据不支持酰基辅酶 A 对母体 IL-13 诱导的体重发展的直接介导作用。